Form 4: ProDex Inc. Director and 10% Owner, Raymond E. Cabillot, Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Raymond E. Cabillot, a director and 10% owner of ProDex Inc., sold a total of 3,026 shares of common stock on January 14th and 15th, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Raymond E. Cabillot, a director and 10% owner of ProDex Inc., executed sales of common stock.
- The sales were conducted under a Rule 10b5-1 trading plan adopted on September 20, 2024.
- On January 14, 2025, 1,147 shares were sold at a weighted average price of $45.18.
- On January 15, 2025, 1,879 shares were sold at a weighted average price of $45.18.
- The shares were sold indirectly through Farnam Street Partners, L.P.
- Following these transactions, Farnam Street Partners, L.P. beneficially owns 352,996 shares.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of insider trading under a pre-arranged plan. It doesn't indicate any positive or negative sentiment about the company's performance.
Risks
- Sales by a director and 10% owner could be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 plan indicates a pre-planned strategy to avoid accusations of trading on non-public information. This is a routine disclosure and does not necessarily indicate a change in the company's prospects.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a standard practice for corporate insiders to sell shares without raising concerns about insider trading.
- Similar filings are common across all publicly traded companies, such as those by executives at companies like Medtronic (MDT) or Boston Scientific (BSX), where pre-planned sales are often disclosed.
- The volume of shares sold is relatively small compared to the total outstanding shares of the company, which is typical for these types of transactions.
Stakeholder Impact
- The sales may have a minor impact on shareholder sentiment, but the pre-planned nature of the transactions should mitigate any significant concerns.
Key Dates
| Date | Description |
|---|---|
| 2024-09-20 | Date the 10b5-1 trading plan was adopted by the reporting persons. |
| 2025-01-14 | Date of the first sale of 1,147 shares of common stock. |
| 2025-01-15 | Date of the second sale of 1,879 shares of common stock. |
Keywords
insider trading, Form 4, 10b5-1 plan, stock sale, beneficial ownership, ProDex Inc., PDEX, Raymond E. Cabillot, Farnam Street Partners
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.